Mechanism and Function of TMEM14 proteins in vertebrate heme synthesis
TMEM14蛋白在脊椎动物血红素合成中的机制和功能
基本信息
- 批准号:9751281
- 负责人:
- 金额:$ 15.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAffinityAnemiaAnimalsBindingBiochemicalBiochemistryBiological AssayCell Culture TechniquesCell LineCell RespirationCell physiologyCellsChemicalsChildComplementDataDefectDevelopmentDevelopment PlansDietary intakeDiseaseDrug Metabolic DetoxicationEnzymesErythrocytesErythroidErythroid CellsErythropoiesisEtiologyFamily memberFetal LiverFetusGenesGeneticGenetic ModelsGoalsHealthHematopoieticHemeHemeproteinsHemoglobinHepaticHepatic TissueHepatocyteHousekeepingHumanIn VitroIndividualIronLeadLifeLightLiverMeasuresMitochondriaMitochondrial MatrixMitochondrial ProteinsMolecularMusMutationOrthologous GeneOxidation-ReductionOxygenPPIXPathologicPathologyPathway interactionsPatientsPenetrancePhysiologicalPhysiological ProcessesPhysiologyPlayPorphyriasPorphyrinsProcessProductionProsthesisProtein FamilyProteinsReactionRespirationRespiratory FailureRoleSeveritiesStructureSubstrate SpecificitySurvival RateTestingTetrapyrrolesTissuesTrainingVertebratesWomanZebrafishanalogbasecareer developmentcell typecofactorgain of function mutationhematopoietic tissuein uteroin vivoin vivo evaluationknock-downmemberprogenitorprotoporphyrin IXpublic health relevancesuccesssynthetic enzymetrafficking
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this proposal is to identify mitochondrial proteins that facilitate the transport of heme intermediates into and within the mitochondria and to outline the physiological processes that require the function of specific transporters of heme synthesis intermediates. I have previously shown that Tmem14c is required for terminal erythropoiesis and import of protoporphyrinogen IX into the mitochondrial matrix for heme synthesis. Tmem14c deficiency causes anemia and porphyrin accumulation in our genetic models. However, several aspects of TMEM14C function and protoporphyrinogen IX transport are still unclear and lead to two main hypotheses that are addressed in my Specific Aims. Firstly, the mechanism by which TMEM14C facilitates the transport of protoporphyrinogen IX is still not understood. As the tight structure of TMEM14C suggests that it functions as a transmembrane channel, I hypothesize that TMEM14C directly transports protoporphyrinogen IX into the mitochondrial matrix. I will test this in Specific Aim 1 by quantifying the relative affinities of TMEM14C to heme and tetrapyrrolic heme intermediates. I will also measure the rates of in vitro heme synthesis in wild-type and Tmem14c deficient mitochondria in the presence of exogenous heme intermediates. Secondly, erythroid cells lacking TMEM14C have survival rates, mitochondrial potentials and mitochondrial masses similar to wild-type cells. As mitochondrial and cellular respiration, which are essential life-sustaining processes require hemoproteins (proteins with heme-cofactors), it is probable that cells possess other protoporphyrinogen IX transporters that maintain housekeeping heme synthesis. As the structures of TMEM14 proteins are very similar, I hypothesize that other members of the TMEM14 superfamily function as protoporphyrinogen IX transporters to maintain housekeeping heme synthesis and cellular physiology. In Specific Aim 2, I will test this hypothesis by knocking down TMEM14 genes in vertebrate cell lines and quantifying the effects of the knockdown on heme synthesis. Candidate TMEM14 genes involved in heme synthesis will be knocked down in primary hepatocytes and primary hematopoietic cells to examine their effect on mitochondrial physiology and hemoglobinization. I will test the in vivo requirement for tmem14 genes in erythroid and hepatic development by knockdown studies in the zebrafish. The completion of my project will shed light on the genetics and biochemistry of the heme synthesis pathway and will contribute to our fundamental understanding of the pathological consequences that occur when the pathway is perturbed by disruptions to the transport of heme intermediates. The specific aims and career development plan described in this proposal are a logical continuation of my prior training but will provide a framework by which I will scientifically and differentiate myself from my advisors, ultimately paving the way for a successful transition to independence.
描述(由适用提供):该提案的长期目标是确定促进血红素中间体进入线粒体内外的线粒体蛋白,并概述需要血红素合成中间体特定转运蛋白功能的物理过程。我先前已经表明,TMEM14C是末端红细胞生成所必需的,并将原磷酸蛋白IX进口到线粒体基质中以进行血红素合成所必需。 TMEM14C缺乏会在我们的遗传模型中引起贫血和卟啉积累。然而,TMEM14C功能和原晶酸IX运输的几个方面尚不清楚,并导致了我的特定目标中提到的两个主要假设。首先,尚不清楚TMEM14C促进原晶IX运输的机制。由于TMEM14C的紧密结构表明它是跨膜通道的作用,因此我假设TMEM14C直接将原甲吡啶原IX转运到线粒体基质中。我将通过量化TMEM14C与血红素和四吡咯血红素中间体的相对亲和力来在特定目标1中进行测试。我还将在存在外源性血红素中间体的情况下测量野生型和TMEM14C缺乏线粒体的体外血红素合成速率。其次,缺乏TMEM14C的红细胞细胞具有与野生型细胞相似的生存率,线粒体电位和线粒体肿块。作为必不可少的生命生命过程的线粒体和细胞呼吸,需要血蛋白(带血红素 - 表现因子的蛋白质),因此细胞具有其他蛋白质卟啉原IX转运蛋白,可维持家政管合成。由于TMEM14蛋白的结构非常相似,因此我假设TMEM14超家族的其他成员充当原磷酸蛋白原IX转运蛋白,以维持管家血红素的合成和细胞生理学。在特定的目标2中,我将通过击倒脊椎动物细胞系中的TMEM14基因并量化敲低对血红素合成的影响来检验这一假设。参与血红素合成的候选TMEM14基因将在原发性肝细胞和原代造血细胞中被击倒,以检查其对线粒体生理和血红蛋白的影响。我将通过斑马鱼中的敲低研究来测试红细胞和肝发育中TMEM14基因的体内需求。我的项目的完成将阐明血红素综合途径的遗传学和生物化学,并将有助于我们对当途径被干扰对血红素中间体的运输扰动时发生的病理后果的基本理解。本提案中描述的具体目的和职业发展计划是我先前培训的逻辑延续,但将提供一个框架,我将科学地与我的顾问区分开来,最终为成功过渡到独立性铺平了道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yvette Y Yien其他文献
Yvette Y Yien的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yvette Y Yien', 18)}}的其他基金
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
- 批准号:
10716494 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10540604 - 财政年份:2019
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10456295 - 财政年份:2019
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10664950 - 财政年份:2019
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10000941 - 财政年份:2019
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10739151 - 财政年份:2019
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
- 批准号:
8677578 - 财政年份:2013
- 资助金额:
$ 15.82万 - 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
- 批准号:
8525515 - 财政年份:2013
- 资助金额:
$ 15.82万 - 项目类别:
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
项目 5 弗拉斯卡蒂介导的线粒体代谢,Barry Paw
- 批准号:
9924635 - 财政年份:
- 资助金额:
$ 15.82万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别:
Investigating how bHLH circuits integrate signals for cell fate decisions
研究 bHLH 电路如何整合信号以决定细胞命运
- 批准号:
10722452 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别: